Look at ARNA and VVUS obesity drugs Approved even with Actual satey issues...DVAX will be Approved as there are no true safety issues just not enough data which was the concern of the board yesterday. Even the Analyst know what's going on....See you at $3.50 Monday...and beyond soon!!!
Ah, didn't both those products have significant delays before they eventually got approved? Also, at least one of them has an onerous risk management program that is significantly hampering sales, and the VVUS product just got rejected by the EU. I don't know what the color of the sky is in your world that would lead you to bellieve that large of a recovery by Monday.